Nucana PLC IPO Research Information

Nucana PLC IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Nucana PLC, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Nucana PLC	NCNA - NASDAQ	$14.00-$16.00	$15.00	$15.50	6.67 million	9/28/2017
Underwriter(s): Citigroup, Jefferies, Cowen
Co-Manager(s): William Blair
Industry: Health Care
Filing(s): Filed 2017-09-01 Terms Added 2017-09-18

Nucana PLC Quote & Chart - Click for current quote - NCNA

About Nucana PLC (adapted from Nucana PLC prospectus):
They are a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer patients by applying our ProTide technology to transform some of the most widely prescribed chemotherapy agents, nucleoside analogs, into more effective and safer medicines.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "NCNA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.